Phizer Inc has dedicated 600 researchers and an annual budget of $270 million to develop new drugs for pets. To date some of the drugs currently marketed by Phizer and their equally concerned (as long as you can afford their concern) competitors include drugs for motion sickness, appetite suppressants, antidepressants for separation anxiety, and doggie dementia blockers.
Related Statistic: In 2007 North Americans spent close to $50 billion on their pets which is roughly twice as much as the combined foreign aid budgets of Canada and the United States.